SE384856B - Sett att framstella indolderivat med anti-inflammatorisk, analgetisk och antipyretisk verkan - Google Patents

Sett att framstella indolderivat med anti-inflammatorisk, analgetisk och antipyretisk verkan

Info

Publication number
SE384856B
SE384856B SE7214215A SE1421572A SE384856B SE 384856 B SE384856 B SE 384856B SE 7214215 A SE7214215 A SE 7214215A SE 1421572 A SE1421572 A SE 1421572A SE 384856 B SE384856 B SE 384856B
Authority
SE
Sweden
Prior art keywords
analgetic
inflammatory
way
antipyretic effects
preparing content
Prior art date
Application number
SE7214215A
Other languages
English (en)
Swedish (sv)
Inventor
G R Birchall
W Hepworth
S C Smith
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Publication of SE384856B publication Critical patent/SE384856B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SE7214215A 1971-11-03 1972-11-02 Sett att framstella indolderivat med anti-inflammatorisk, analgetisk och antipyretisk verkan SE384856B (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1811672A GB1356834A (en) 1971-11-03 1971-11-03 Indole derivatives
GB1811672 1972-04-19
GB3076772 1972-06-30

Publications (1)

Publication Number Publication Date
SE384856B true SE384856B (sv) 1976-05-24

Family

ID=27257588

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7214215A SE384856B (sv) 1971-11-03 1972-11-02 Sett att framstella indolderivat med anti-inflammatorisk, analgetisk och antipyretisk verkan

Country Status (17)

Country Link
US (1) US3884919A (xx)
JP (1) JPS4856667A (xx)
AR (3) AR198064A1 (xx)
BE (1) BE790679A (xx)
CA (1) CA983932A (xx)
CH (1) CH577499A5 (xx)
DD (1) DD105611A5 (xx)
DE (1) DE2253927A1 (xx)
EG (1) EG11358A (xx)
ES (2) ES408226A1 (xx)
FR (1) FR2158464B1 (xx)
GB (1) GB1356834A (xx)
HU (1) HU169711B (xx)
IE (1) IE37998B1 (xx)
IL (1) IL40521A (xx)
NL (1) NL7214807A (xx)
SE (1) SE384856B (xx)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4022780A (en) * 1973-03-06 1977-05-10 Imperial Chemical Industries Limited Process for the manufacture of indole derivatives
FR2421900A1 (fr) * 1977-03-17 1979-11-02 Sauba Lab Piperazino-3-indoles, leur procede de preparation et leurs applications therapeutiques
US4316847A (en) * 1979-07-30 1982-02-23 Hoffmann-La Roche Inc. Pyrroles and pyrrolidines
US4459227A (en) * 1981-03-02 1984-07-10 Duke University Para-hydroxyphenylhydrazines as in situ precursors of iminoquinones and quinones
EP0746554A1 (en) * 1994-02-23 1996-12-11 Pfizer Inc. 4-heterocyclyl-substituted quinazoline derivatives, processes for their preparation and their use as anti-cancer agents
US6252084B1 (en) * 1994-03-15 2001-06-26 Eli Lilly And Company 1H-indole-3-acetamide sPLA2 inhibitors
IL137719A0 (en) * 1998-02-25 2001-10-31 Genetics Inst Inhibitors of phospholipase enzymes
US6500853B1 (en) 1998-02-28 2002-12-31 Genetics Institute, Llc Inhibitors of phospholipase enzymes
SE0200411D0 (sv) * 2002-02-05 2002-02-05 Astrazeneca Ab Novel use
SE0200356D0 (sv) * 2002-02-05 2002-02-05 Astrazeneca Ab Novel use
TW200307542A (en) 2002-05-30 2003-12-16 Astrazeneca Ab Novel compounds
SE0201635D0 (sv) 2002-05-30 2002-05-30 Astrazeneca Ab Novel compounds
SE0202241D0 (sv) 2002-07-17 2002-07-17 Astrazeneca Ab Novel Compounds
SE0301009D0 (sv) * 2003-04-07 2003-04-07 Astrazeneca Ab Novel compounds
SE0301010D0 (sv) * 2003-04-07 2003-04-07 Astrazeneca Ab Novel compounds
PT1471057E (pt) 2003-04-25 2006-05-31 Actimis Pharmaceuticals Inc Derivados de acido pirimidinilacetico uteis para o tratamento de doencas mediadas por crth2
ES2290743T3 (es) * 2003-04-30 2008-02-16 The Institutes For Pharmaceutical Discovery, Llc Heteroarilos sustituidos como inhibidores de las proteina-tirosina fosfatasas.
SE0301569D0 (sv) 2003-05-27 2003-05-27 Astrazeneca Ab Novel compounds
SE0302232D0 (sv) 2003-08-18 2003-08-18 Astrazeneca Ab Novel Compounds
SA04250253B1 (ar) 2003-08-21 2009-11-10 استرازينيكا ايه بي احماض فينوكسي اسيتيك مستبدلة باعتبارها مركبات صيدلانية لعلاج الامراض التنفسية مثل الربو ومرض الانسداد الرئوي المزمن
GB0324763D0 (en) 2003-10-23 2003-11-26 Oxagen Ltd Use of compounds in therapy
SE0303180D0 (sv) 2003-11-26 2003-11-26 Astrazeneca Ab Novel compounds
PT1718649E (pt) 2004-01-31 2009-08-06 Actimis Pharmaceuticals Inc Derivados de ácido imidazo[1,2-c]pirimidinilacético
GB0415320D0 (en) 2004-07-08 2004-08-11 Astrazeneca Ab Novel compounds
GB0418830D0 (en) 2004-08-24 2004-09-22 Astrazeneca Ab Novel compounds
WO2006056752A1 (en) 2004-11-23 2006-06-01 Astrazeneca Ab Phenoxyacetic acid derivatives useful for treating respiratory diseases
GB0500604D0 (en) 2005-01-13 2005-02-16 Astrazeneca Ab Novel process
TW200745003A (en) 2005-10-06 2007-12-16 Astrazeneca Ab Novel compounds
JP5155171B2 (ja) 2005-10-06 2013-02-27 アストラゼネカ・アクチエボラーグ 新規化合物
JP2009538289A (ja) 2006-05-26 2009-11-05 アストラゼネカ・アクチエボラーグ ビアリールまたはヘテロアリール置換インドール
PL2046740T3 (pl) 2006-07-22 2012-10-31 Oxagen Ltd Związki o aktywności antagonisty CRTH2
UA100983C2 (xx) 2007-07-05 2013-02-25 Астразенека Аб Біфенілоксипропанова кислота як модулятор crth2 і інтермедіати$бифенилоксипропановая кислота как модулятор crth2 и интермедиаты
SI2205569T1 (sl) 2007-09-25 2012-06-29 Actimis Pharmaceuticals Inc Alkiltio pirimidini kot crth2 antagonisti
CN101874024A (zh) 2007-09-25 2010-10-27 艾克提麦斯医药品有限公司 作为crth2拮抗剂的2-s-苄基取代的嘧啶
US7750027B2 (en) 2008-01-18 2010-07-06 Oxagen Limited Compounds having CRTH2 antagonist activity
MX2010007833A (es) 2008-01-18 2010-08-11 Oxagen Ltd Compuestos que tienen actividad antagonista de crth2.
JP2011509991A (ja) 2008-01-22 2011-03-31 オキサジェン リミテッド Ｃｒｔｈ２アンタゴニスト活性を有する化合物
WO2009093026A1 (en) 2008-01-22 2009-07-30 Oxagen Limited Compounds having crth2 antagonist activity
GB201322273D0 (en) 2013-12-17 2014-01-29 Atopix Therapeutics Ltd Process
GB201407807D0 (en) 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form
GB201407820D0 (en) 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form
CN113164761A (zh) * 2018-10-05 2021-07-23 弗特克斯药品有限公司 α-1抗胰蛋白酶的调节剂

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL125443C (xx) * 1963-06-06
US3679692A (en) * 1969-10-01 1972-07-25 Mead Johnson & Co Iminomethylindolines

Also Published As

Publication number Publication date
AR198064A1 (es) 1974-05-31
CA983932A (en) 1976-02-17
BE790679A (fr) 1973-04-27
DD105611A5 (xx) 1974-05-05
US3884919A (en) 1975-05-20
FR2158464A1 (xx) 1973-06-15
AR203626A1 (es) 1975-09-30
HU169711B (xx) 1977-02-28
EG11358A (en) 1977-02-28
NL7214807A (xx) 1973-05-07
IE37998L (en) 1973-05-03
AR203627A1 (es) 1975-09-30
IL40521A0 (en) 1972-12-29
CH577499A5 (xx) 1976-07-15
IL40521A (en) 1975-06-25
FR2158464B1 (xx) 1976-07-02
DE2253927A1 (de) 1973-05-10
JPS4856667A (xx) 1973-08-09
ES408226A1 (es) 1976-02-01
IE37998B1 (en) 1977-12-07
GB1356834A (en) 1974-06-19
ES437311A1 (es) 1977-04-01

Similar Documents

Publication Publication Date Title
SE384856B (sv) Sett att framstella indolderivat med anti-inflammatorisk, analgetisk och antipyretisk verkan
FI55379B (fi) Polyolefinmassa med baettre vattenavledningsegenskaper foer framstaellning av papper och massans framstaellningsfoerfarande
SE7602339L (sv) Kinolonderivat och sett att framstella desamma
SE398877B (sv) Forfarande for framstellning av 14-hydroxi-morfinanderivat
SE7605925L (sv) Nya prostanderivat och sett att framstella desamma
SE405599B (sv) Forfarande for framstellning av pyridazinoner med terapeutisk verkan
SE402283B (sv) Karbazoler med antiinflammatorisk, analgetisk och antireumatisk verkan
SE406197B (sv) Analogiforfarande for framstellning av 4-aminokinazolinderivat
SE7508544L (sv) Bensimidazol-derivat och sett att framstella desamma.
BE786155A (fr) Derives heterocycliques n-substitues ainsi que leur preparation
SE397523B (sv) Forfarande att framstella n-fenylpyrrolderivat med antiinflammatorisk och analgetisk verkan
FI54592C (fi) Foerpackning av straengar av med adhesionsmedel belagda glasfibrer och foerfarande foer framstaellning av foerpackningen
FI56100B (fi) Loesningskoncentrat med fungicid och acaricid verkan
SE395892B (sv) Forfarande for framstellning av piperidyl-bensimidazoliner med terapeutisk verkan
SE392615B (sv) Forfarande for framstellning av 2-nitro-5-imidazolaldehydderivat
SE384686B (sv) Forfarande for framstellning av linkomycinderivat
SE399069B (sv) Analogiforfarande for framstellning av triazolo-pyridino-isokinolin-derivat
SE385896B (sv) Forfarande for framstellning av 2,3-dihydro-4h-tieno-(3,2-c)(1)bensopyran-4-oner med analgetisk och antipyretisk verkan
SE408177B (sv) Forfarande for framstellning av 4-hydroximetyl-1-ftalazonderivat
SE401829B (sv) Forfarande for framstellning av 5-fenyl-6,7-bensomorfanderivat och salter derav
FI53790B (fi) Foerfarande och anordning foer styrd gjutning av en form med smaelt metall
SE394680B (sv) Forfarande for framstellning av cykliska fosfamidderivat
SE409866B (sv) Forfarande for framstellning av adenosinderivat
SE405730B (sv) Forfarande for framstellning av kinazolinderivat
SE397350B (sv) Forfarande for framstellning av tieno-diazepinderivat